CC趋化因子受体与炎症性肠病

被引:8
作者
叶小研
钟英强
机构
[1] 中山大学孙逸仙纪念医院消化内科
关键词
趋化因子,CC; 受体,CCR; 炎症性肠病;
D O I
暂无
中图分类号
R574 [肠疾病];
学科分类号
100201 [内科学];
摘要
炎症部位白细胞聚集和活化是炎症性肠病(IBD)的重要特征,趋化因子受体是趋化白细胞的重要调节因子。在IBD中,多种趋化因子受体表达上调,触发多种炎症反应。本文就CC趋化因子受体(CCR)在IBD中的作用及其作为IBD治疗靶点的可能性作一综述。
引用
收藏
页码:50 / 53
页数:4
相关论文
共 12 条
[1]
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis [J].
Saskia Thomas ;
Daniel C. Baumgart .
Inflammopharmacology, 2012, 20 (1) :1-18
[2]
CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated Remodeling [J].
Masterson, Joanne C. ;
McNamee, Eoin N. ;
Jedlicka, Paul ;
Fillon, Sophie ;
Ruybal, Joseph ;
Hosford, Lindsay ;
Rivera-Nieves, Jesus ;
Lee, James J. ;
Furuta, Glenn T. .
AMERICAN JOURNAL OF PATHOLOGY, 2011, 179 (05) :2302-2314
[3]
Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies [J].
Manousou, P. ;
Kolios, G. ;
Valatas, V. ;
Drygiannakis, I. ;
Bourikas, L. ;
Pyrovolaki, K. ;
Koutroubakis, I. ;
Papadaki, H. A. ;
Kouroumalis, E. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 162 (02) :337-347
[4]
Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis [J].
Rivera-Nieves, Jesus ;
Ho, Johnson ;
Bamias, Giorgos ;
Ivashkina, Natalia ;
Ley, Klaus ;
Oppermann, Martin ;
Cominelli, Fabio .
GASTROENTEROLOGY, 2006, 131 (05) :1518-1529
[5]
Treatment with Met-RANTES decreases bacterial translocation in experimental colitis [J].
Kucuk, C ;
Sozuer, E ;
Gursoy, S ;
Canoz, O ;
Artis, T ;
Akcan, A ;
Akyildiz, H ;
Muhtaroglu, S .
AMERICAN JOURNAL OF SURGERY, 2006, 191 (01) :77-83
[6]
Expression of chemokine receptors in normal and inflamed human intestine; tonsil; and liver—An immunohistochemical analysis with new monoclonal antibodies from the 8th international workshop and conference on human leucocyte differentiation antigens.[J].Frank Autschbach;Benjamin Funke;Marianna Katzenmeier;Nikolaus Gassler.Cellular Immunology.2005, 1
[7]
Increased expression of CCL20 in human inflammatory bowel disease [J].
Kaser, A ;
Ludwiczek, O ;
Holzmann, S ;
Moschen, AR ;
Weiss, G ;
Enrich, B ;
Graziadei, I ;
Dunzendorfer, S ;
Wiedermann, CJ ;
Mürzl, E ;
Grasl, E ;
Jasarevic, Z ;
Romani, N ;
Offner, FA ;
Tilg, H .
JOURNAL OF CLINICAL IMMUNOLOGY, 2004, 24 (01) :74-85
[8]
CCR6 has a non-redundant role in the development of inflammatory bowel disease [J].
Varona, R ;
Cadenas, V ;
Flores, J ;
Martínez-A, C ;
Márquez, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (10) :2937-2946
[9]
Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis [J].
Berrebi, D ;
Languepin, J ;
Ferkdadji, L ;
Foussat, A ;
De Lagausie, P ;
Paris, R ;
Emilie, D ;
Mougenot, JF ;
Cezard, JP ;
Navarro, J ;
Peuchmaur, M .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 37 (03) :300-308
[10]
Differential expression of CCR5 and CRTH2 on infiltrated cells in colonic mucosa of patients with ulcerative colitis [J].
Matsuzaki, K ;
Hokari, R ;
Kato, S ;
Tsuzuki, Y ;
Tanaka, H ;
Kurihara, C ;
Iwai, A ;
Kawaguchi, A ;
Nagao, S ;
Itoh, K ;
Nagata, K ;
Miura, S .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (09) :1081-1088